Pending LARA Bill Could Disallow Gag-Orders in Product Liability Settlements
This article was originally published in The Gray Sheet
Executive Summary
An amendment to the Lawsuit Abuse Reduction Act (LARA) that would make it more difficult for firms in product liability settlements to secure a gag-order could be introduced when the legislation goes to a floor vote, House Judiciary Committee staffers suggest
You may also be interested in...
Will Class Action Fairness Act Pave Way for HEALTH Liability Reform?
The pending "HEALTH" bill - if it passes - may have a greater impact on medical device litigation than the newly enacted class action bill
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.